Active Infection & Immunity

Kemri-Wellcome Trust Research Programme (KWTRP) core funding renewal 2023-2030. (Kenya AAP)

In plain English

AI plain-English summary

The Programme runs a distributed research platform across Kenya, tackling the country's most pressing public health problems through locally-led science. This matters because many of the diseases that kill and disable people in East Africa—from malaria to pneumonia to emerging threats like COVID-19—cannot be solved by importing solutions from elsewhere. The Programme fills a gap by building the scientific workforce and infrastructure within the region, so that research questions are shaped by the people who live with these diseases every day. If the research succeeds, it could change how care is delivered across the health system, reduce deaths through better vaccines and clinical treatments, and uncover fundamental biology that leads to entirely new interventions. The work also strengthens the quiet infrastructure that keeps public health running: disease surveillance networks, laboratory capacity, community trust, and the policy links that turn evidence into action. By training the next generation of African scientists, the Programme ensures that this capacity endures beyond any single project.

View original technical description
We are a diverse, multi-disciplinary research Programme with a vision for transformative research in national and international health. We believe that transformative research is led from within the region, that impactful research requires inter-disciplinary collaborative work, and that development and training of scientists in the region is imperative. We take a distributed and inter-disciplinary approach to scientific leadership, in order to empower a diverse range of principal investigators to develop and lead ambitious research at the most pressing public health problems, supported by an integrated and coordinated research platform, that facilitates and promotes collaboration in cross-disciplinary research themes. Our strategic aims are to produce impactful research throughout the translational pathway, from the broad systems perspective to transform the delivery of care (e.g. “Health Systems”), through translational work to reduce mortality with evidence-based prevention or treatment (e.g. “Vaccines” or “Clinical Care”); to discovery of the fundamental biology to produce the next generation of interventions (e.g. “Pathogen Biology”). We nurture close partnerships with our communities and participants, the wider public, and policy makers. We respond rapidly and flexibly to emerging public health needs, as shown by the broad multi- disciplinary response to COVID.

View the original record at the funder ↗

Researchers

Anthony Etyang (EPMC Awardee)Dorcas Kamuya (EPMC Awardee)Edwine Barasa (EPMC Awardee)George Warimwe (EPMC Awardee)Joseph Mwangangi (EPMC Awardee)Kathryn Maitland (EPMC Awardee)Lynette Oyier (EPMC Awardee)Mainga Hamaluba (EPMC Awardee)Noni Mumba (EPMC Awardee)Peter Olupot-Olupot (EPMC Awardee)Samson Kinyanjui (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Core Support for the East African Major Overseas Programme
Developing research capacity and leadership in East Africa from the KEMRI- Wellcome Trust Research Programme, Kenya
Africa Health Research Institute - Core Renewal 2023-30 (GBP)
Enhancing evidence informed decision making (EEVIDEM) for health in Kenya
NIHR Global Health Research Group on the Application of Genomics and Modelling to the Control of Virus Pathogens (GeMVi) in East Africa at the University of Warwick.

Original classification

Africa and Asia Programme Renewal

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.